Sat May 30, 2009, 05:04 AM
|
|
Member
|
|
Join Date: Oct 2007
Location: Stockholm, Sweden
Posts: 1,918
|
|
|
Sapacitabine Phase II results
Hi All,
Now the first results from trials with Sapacitabine are presented: In the ongoing MDS stratum thus far 31 patients aged above 60 years have been treated with Sapacitabine as second line therapy following treatment with hypomethylating agents. Complete remission and hematological improvement have been observed in 7 patients.
http://production.investis.com/cyc/i...09/2009-05-29/
Kind regards
Birgitta-A |